磷酸化失调症蛋白1抗体

英文名称 phospho-ATXN1(Thr236)
中文名称 磷酸化失调症蛋白1抗体
别    名 ATXN1; ATX1; D6S504E; SCA1; Ataxin-1; Spinocerebellar ataxia type 1; ATX1_RAT.
磷酸化失调症蛋白1抗体
说 明 书
产品类型 磷酸化抗体 
研究领域 肿瘤  免疫学  神经生物学  信号转导  细胞凋亡  转录调节因子  
抗体来源 Rabbit
克隆类型 Polyclonal
交叉反应 Mouse, Rat, 
产品应用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 90kDa
细胞定位 细胞核 细胞浆 
性    状 Lyophilized or Liquid
浓    度 1mg/1ml
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human ATXN1 around the phosphorylation site of Thr236
亚    型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
产品介绍 background:
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains41-81 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1).

Function:
Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression. Binds RNA in vitro. May be involved in RNA metabolism. The expansion of the polyglutamine tract may alter this function.

Subunit:
Homooligomer. Interacts with CIC. Interacts with ANP32A, PQBP1, UBQLN4, ATXN1L, USP7 and ZNF804A. Directly interacts with RBPJ; this interaction is disrupted in the presence of Notch intracellular domain. Competes with ATXN1L for RBPJ-binding.

Subcellular Location:
Cytoplasm. Nucleus. Note=Colocalizes with USP7 in the nucleus.

Tissue Specificity:
Widely expressed throughout the body.

Post-translational modifications:
Phosphorylation at Ser-775 increases the pathogenicity of proteins with an expanded polyglutamine tract.
Sumoylation is dependent on nuclear localization and phosphorylation at Ser-775. It is reduced in the presence of an expanded polyglutamine tract.

DISEASE:
Spinocerebellar ataxia 1 (SCA1) [MIM:164400]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease. Note=The disease is caused by mutations affecting the gene represented in this entry.

Similarity:
Belongs to the ATXN1 family.
Contains 1 AXH domain.

Gene ID:
6310

Database links:

Entrez Gene: 6310 Human

Entrez Gene: 20238 Mouse

Omim: 601556 Human

SwissProt: P54253 Human

SwissProt: P54254 Mouse

Unigene: 434961 Human

Unigene: 342683 Mouse

Unigene: 342686 Mouse

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.xy-12921R phospho-CK18(Ser52)磷酸化细胞角蛋白18抗体
xy-12922R Cytohesin 2胞粘蛋白2抗体
xy-12923R Cytochrome P450 2A6细胞色素CPA6抗体
xy-12924R CYP3A1细胞色素CYP3A抗体
xy-12927R CYP20A1细胞色素cP450 CYP20A1抗体
xy-12926R CYP1B1细胞色素cP4501B1抗体
xy-12928R CYP26A1细胞色素cP450 CYP26A1抗体
xy-12929R phospho-Cyclin E(Thr77)磷酸化周期素E抗体
xy-12930R phospho-Cyclin E2 (Thr392)磷酸化周期素E2抗体
xy-12045R Cyclin M3周期素M3抗体
xy-12060R Cyclin Y周期素Y/X抗体
xy-12155R phospho-Cyclin D3 (Thr283)磷酸化周期素D3抗体
xy-12162R CYB5R3细胞色素b5还原酶3抗体
xy-11464R CWC22CWC22蛋白抗体
xy-15349R C9orf959号染色体开放阅读框95抗体
xy-13794R C19orf6719号染色体开放阅读框67抗体
xy-12426R phospho-Casein kinase I isoforms gamma 1+2+3 ( Tyr263)磷酸化酪蛋白激酶1γ1+γ2+γ3抗体
xy-8860R Coproporphyrinogen III Oxidase原卟啉氧化酶3抗体
xy-8987R Connexin 43间隙连接蛋白43抗体
xy-13745R CLDN25紧密连接蛋白25抗体
xy-13863R CEP78中心体蛋白78抗体
xy-15223R C6orf1466号染色体开放阅读框146抗体
xy-15226R C6ORF1546号染色体开放阅读框154抗体
xy-15316R C9orf169号染色体开放阅读框16抗体
xy-15342R C9orf789号染色体开放阅读框78抗体